Evidence map›Paper›PMID 29951395›Full record

ArticleMedical journal of the Islamic Republic of Iran2017

Cost-effectiveness analysis of subcutaneous immunoglobulin replacement therapy in Iranian patients with primary immunodeficiencies.

Hosein Shabaninejad, Asra Asgharzadeh, Aziz Rezapour, Nima Rezaei

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Medical journal of the Islamic Republic of Iran, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Hosein ShabaninejadDepartment of Health Management, School of Health Management & Information Sciences, Iran University of Medical Sciences, Tehran, Iran.
Asra AsgharzadehSchool of Health Management & Information Sciences, Iran University of Medical Sciences, Tehran, Iran, & Health Technology Assessment Group (HTAG), Universal Scientific Education and Research Network (USERN), Tehran, Iran.
Aziz RezapourHealth Management and Economics Research Center, Iran University of Medical Sciences, Tehran, Iran.
Nima RezaeiResearch Center for Immunodeficiencies Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran, & Department of Immunology and Biology, School of Medicine Tehran University of Medical Sciences, Tehran, Iran, & Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA) Universal Scientific Education and Research Network (USERN), Tehran, Iran.
Iran University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Cost-effectivenessIntravenous immunoglobulinPrimary immunodeficiencySubcutaneous immunoglobulin

Identifiers

PMID29951395
PMCPMC6014784
OpenAlexW2792472537

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.